FR2455028A1 - Nouveaux amides d'acylcarnitines, utiles notamment comme stimulants du systeme nerveux central, et leur procede de preparation - Google Patents
Nouveaux amides d'acylcarnitines, utiles notamment comme stimulants du systeme nerveux central, et leur procede de preparationInfo
- Publication number
- FR2455028A1 FR2455028A1 FR8009149A FR8009149A FR2455028A1 FR 2455028 A1 FR2455028 A1 FR 2455028A1 FR 8009149 A FR8009149 A FR 8009149A FR 8009149 A FR8009149 A FR 8009149A FR 2455028 A1 FR2455028 A1 FR 2455028A1
- Authority
- FR
- France
- Prior art keywords
- amino
- group
- acylcarnitin
- amides
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/89—Carboxylic acid amides having nitrogen atoms of carboxamide groups quaternised
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
LES MEDICAMENTS DE L'INVENTION REPONDENT A LA FORMULE GENERALE: (CF DESSIN DANS BOPI) DANS LAQUELLE X EST UN ANION HALOGENURE, DE PREFERENCE CL; R EST UN GROUPE ACETYLE, HALOGENOACETYLE (PAR EXEMPLE CHLOROACETYLE, DICHLOROACETYLE, BROMOACETYLE, ETC.), PROPIONYLE, HALOGENOPROPIONYLE (PAR EXEMPLE BROMOPROPIONYLE), BUTYRYLE, HALOGENOBUTYRYLE (PAR EXEMPLE CHLOROBUTYRYLE), ISOBUTYRYLE, B-HYDROXYBUTYRYLE, ACETOACETYLE, LINOLEYLE OU PANTOTHENYLE; ET R EST UN GROUPE AMINO (A CONDITION QUE R NE SOIT PAS UN GROUPE ACETYLE), 2-SULFONYLETHYLAMINO, (2-HYDROXY-3-CARBETHOXYPROPYL)AMINO, (1-CARBOMETHOXY-2-METHYLPROPYL)AMINO, (1-CARBOMETHOXY-3-METHYL-N-BUTYL)AMINO, (1-CARBOMETHOXY-2-METHYL-N-BUTYL)-AMINO, (1,2-DICARBOMETHOXYETHYL)AMINO, (1,3-DICARBOMETHOXYPROPYL)-AMINO, A-CARBETHOXYBENZYLAMINO, 4-CARBETHOXYPHENYLAMINO, (2-MERCAPTO-1-CARBOMETHOXYETHYL)AMINO,2-MERCAPTOETHYLAMINO, (5-TRIMETHYLAMMONIOCHLORURE-1-CARBETHOXYPENTYL)AMINO, CARBETHOXYMETHYLAMINO ET CARBETHOXYETHYLAMINO. APPLICATION POUR LE TRAITEMENT DES ARYTHMIES FONCTIONNELLES ET ARYTHMIES SECONDAIRES DANS LES MALADIES MYOCARDIENNES SCLEROTIQUES ET DES DEPRESSIONS INDUITES PAR LES BARBITURIQUES ET COMME PSYCHOSTIMULANT, NOTAMMENT EN UNITES DE DOSAGE CONTENANT ENVIRON 5 A 500MG DE L'INGREDIENT ACTIF DE FORMULE(I).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT48816/79A IT1116037B (it) | 1979-04-23 | 1979-04-23 | Esteri e ammidi di acil carnitine loro procedimenti di preparazione e loro uso terapeutico |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2455028A1 true FR2455028A1 (fr) | 1980-11-21 |
FR2455028B1 FR2455028B1 (fr) | 1983-04-08 |
Family
ID=11268672
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR8009148A Expired FR2455027B1 (fr) | 1979-04-23 | 1980-04-23 | Esters d'acylcarnitines utiles comme medicaments, leurs procedes de preparation et compositions therapeutiques les contenant |
FR8009149A Granted FR2455028A1 (fr) | 1979-04-23 | 1980-04-23 | Nouveaux amides d'acylcarnitines, utiles notamment comme stimulants du systeme nerveux central, et leur procede de preparation |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR8009148A Expired FR2455027B1 (fr) | 1979-04-23 | 1980-04-23 | Esters d'acylcarnitines utiles comme medicaments, leurs procedes de preparation et compositions therapeutiques les contenant |
Country Status (19)
Country | Link |
---|---|
US (2) | US4443475A (fr) |
JP (3) | JPS562945A (fr) |
AT (2) | AT376656B (fr) |
AU (2) | AU538740B2 (fr) |
BE (2) | BE882937A (fr) |
CH (2) | CH642619A5 (fr) |
DE (2) | DE3015635A1 (fr) |
DK (2) | DK170680A (fr) |
ES (2) | ES8104191A1 (fr) |
FR (2) | FR2455027B1 (fr) |
GB (2) | GB2051779B (fr) |
GR (2) | GR68051B (fr) |
IE (2) | IE49701B1 (fr) |
IL (2) | IL59915A (fr) |
IT (1) | IT1116037B (fr) |
LU (2) | LU82387A1 (fr) |
NL (2) | NL8002369A (fr) |
NO (2) | NO151823C (fr) |
SE (2) | SE448375B (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2474489A1 (fr) * | 1980-01-29 | 1981-07-31 | Sigma Tau Ind Farmaceuti | Carnitinamides d'aminoacides optiquement actifs, leur procede de preparation et leur application en therapeutique |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1120033B (it) | 1979-10-05 | 1986-03-19 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica comprendente-carnitina adatta per l'alimentazione parenterale |
IT1147079B (it) * | 1980-05-30 | 1986-11-19 | Sigma Tau Ind Farmacuetiche Ri | Esteri di alcossi-acil derivati della carnitina procedimento per la loro preparatione e composizioni farmaceutiche che li contengono |
US4405642A (en) * | 1980-11-28 | 1983-09-20 | American Hospital Supply Corporation | Method for treatment or prophylaxis of cardiac disorders |
IT1170861B (it) * | 1981-03-31 | 1987-06-03 | Sigma Tau Ind Farmaceuti | Ester di mercaptoacil-carnitine procedimento per la loro preparazione e loro uso terapeutico |
IT1170862B (it) * | 1981-03-31 | 1987-06-03 | Sigma Tau Ind Farmaceuti | Mercaptoacil-carnitine procedimento per la loro preparazione e loro uso terapeutico |
IT1171360B (it) * | 1981-07-03 | 1987-06-10 | Sigma Tau Ind Farmaceuti | Procedimento per la preparazione del cloruro acido di carnitina |
IT1172127B (it) * | 1981-12-03 | 1987-06-18 | Sigma Tau Ind Farmaceuti | Tioacil - carnitine procedimento per la loro preparazione e composizioni farmaceutiche che le contengono ad azione mucclitica |
IT1177874B (it) * | 1984-07-04 | 1987-08-26 | Sigma Tau Ind Farmaceuti | Estere della acetil carnitina,procedimenti per la sua preparazione e composizioni farmaceutiche che lo contengono |
US4897355A (en) * | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
US5545412A (en) * | 1985-01-07 | 1996-08-13 | Syntex (U.S.A.) Inc. | N-[1, (1-1)-dialkyloxy]-and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-n,n,n-tetrasubstituted ammonium lipids and uses therefor |
IT1201481B (it) * | 1985-10-08 | 1989-02-02 | Prodotti Antibiotici Spa | Pantotenil derivati |
US4866040A (en) * | 1986-01-06 | 1989-09-12 | Alfred Stracher | Aminocarnitine directed pharmaceutical agents |
US5008288A (en) * | 1986-01-06 | 1991-04-16 | Alfred Stracher | Carnitine directed pharmaceutical agents |
IT1224842B (it) * | 1988-12-27 | 1990-10-24 | Sigma Tau Ind Farmaceuti | Uso di derivati della l-carnitina nel trattamento terapeutico delle alterazioni degenerative del sistema nervoso |
IT1230141B (it) * | 1989-05-03 | 1991-10-14 | Fidia Spa | Impiego di derivati della fosfatidil carnitina per la preparazione di composizioni farmaceutiche aventi attivita' nella terapia delle patologie dell'uomo associate con un danno neuronale. |
IT1238344B (it) * | 1989-10-20 | 1993-07-13 | Sigma Tau Ind Farmaceuti | Estere della l-carnitina con l'acido gamma-idrossibutirrico e composizioni farmaceutiche che lo contengono per l'inibizione della degenerazione neuronale e nel trattamento del coma |
IT1240760B (it) * | 1990-02-12 | 1993-12-17 | Sigma Tau Ind Farmaceuti | Esteri di acil-l-carnitine con l'acido gamma-idrossibutirrico e composizioni farmaceutiche che li contengono per l'inibizione della degenerazione neuronale e nel trattamento del coma. |
IT1240775B (it) * | 1990-02-23 | 1993-12-17 | Sigma Tau Ind Farmaceuti | Esteri della l-carnitina e di acil-l-carnitine con l'acido beta-idrossibutirrico e composizioni farmaceutiche che li contengono per la inibizione della degenerazione neuronale, della proteolisi epatica e nel trattamento del coma. |
IT1240799B (it) * | 1990-03-15 | 1993-12-17 | Sigma Tau Ind Farmaceuti | Composizioni farmaceutiche contenenti 3-metiltiopropionil l-carnitina ad attivita' sul sistema cardiovascolare. |
US5168023A (en) * | 1990-07-04 | 1992-12-01 | Matsushita Electric Industrial Co., Ltd. | Photosensitive element used in electrophotography |
IT1248323B (it) * | 1991-05-16 | 1995-01-05 | Sigma Tau Ind Farmaceuti | Ammidi con amminoacidi naturali di alcanoil l-carnitine quali inibitori della degenerazione neuronale e attivatori dei processi di apprendimento e memorizzazione e per il trattamento del coma e composizioni farmaceutiche comprendenti tali composti |
IT1254135B (it) * | 1992-01-16 | 1995-09-08 | Sigma Tau Ind Farmaceuti | Esteri di acil carnitine con alcooli alifatici a lunga catena e composizioni farmaceutiche che li contengono, ad attivita' antibatterica. |
IT1254136B (it) * | 1992-01-16 | 1995-09-08 | Sigma Tau Ind Farmaceuti | Esteri di acil carnitine con alcooli alifatici a lunga catena e composizioni farmaceutiche che li contengono, ad attivita' antimicotica. |
IT1258370B (it) * | 1992-03-02 | 1996-02-26 | Sigma Tau Ind Farmaceuti | Esteri della l-carnitina e di acil l-carnitine dotati di attivita' miorilassante selettiva sull'apparato gastro-intestinale e composizioni farmaceutiche che li contengono. |
IT1263013B (it) * | 1992-10-20 | 1996-07-23 | Avantgarde Spa | Esteri della l-carnitina e di alcanoil l-carnitine con l'acido glicolico o suoi esteri e composizioni farmaceutiche contenenti tali per il trattamento di affezioni cutanee. |
IT1261231B (it) * | 1993-04-08 | 1996-05-09 | Sigma Tau Ind Farmaceuti | Procedimento migliorato per la preparazione di l-(-)-carnitina a partire da un prodotto di scarto avente opposta configurazione. |
IT1261688B (it) * | 1993-05-28 | 1996-05-29 | Avantgarde Spa | Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee. |
IT1261828B (it) * | 1993-07-14 | 1996-06-03 | Sigma Tau Ind Farmaceuti | Esteri di acil l-carnitine e composizioni farmaceutiche che li contengono per il trattamento dello shock endotossico. |
US5741816A (en) * | 1994-06-20 | 1998-04-21 | Tanabe Seiyaku Co., Ltd. | Hair-growth agent |
IT1299172B1 (it) * | 1998-05-06 | 2000-02-29 | Sigma Tau Ind Farmaceuti | Esteri perfluorurati di alcanoil l-carnitine utilizzabili quali lipidi cationici per l'immissione intracellulare di composti |
ITRM20020620A1 (it) * | 2002-12-13 | 2004-06-14 | Sigma Tau Ind Farmaceuti | Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa. |
FI20030769A0 (fi) * | 2003-05-21 | 2003-05-21 | Raisio Chem Oy | Tärkkelysjohdannaiset, niiden valmistus ja käyttö |
ATE520717T1 (de) * | 2003-05-21 | 2011-09-15 | Basf Se | Verfahren zur herstellung von estern des carnitins und ihre verwendung. |
US20050232911A1 (en) * | 2004-04-19 | 2005-10-20 | Schreiber Brian D | Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid |
JP5485492B2 (ja) * | 2004-12-15 | 2014-05-07 | 大正製薬株式会社 | うつ病の予防・治療薬 |
WO2008075366A2 (fr) * | 2006-12-20 | 2008-06-26 | Medwell Laboratories Ltd. | Nouveaux conjugués d'acides gras poly-insaturés avec des amines et utilisations thérapeutiques de ceux-ci |
JP2011514809A (ja) * | 2008-03-13 | 2011-05-12 | パーキンエルマー ラス インコーポレイテッド | 多重検出システムのための酵素基質 |
EP2216321A1 (fr) * | 2009-02-05 | 2010-08-11 | Lonza Ltd. | Processus de production de dérivé de carnitine/acide gras |
CN102557972A (zh) * | 2011-12-31 | 2012-07-11 | 南京海辰药业有限公司 | 氯化乙酰左卡尼汀的多晶型物 |
CN104161728A (zh) * | 2013-05-17 | 2014-11-26 | 北京星昊医药股份有限公司 | 氯化丙酰左卡尼汀冻干粉针剂及其制备方法 |
CN104163769B (zh) * | 2014-06-23 | 2016-06-15 | 海南霞迪药业有限公司 | 一种氯化丙酰左卡尼汀的制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4032641A (en) * | 1976-06-09 | 1977-06-28 | Tanabe Seiyaku Co., Ltd. | Nicotinoyl carnitine derivatives |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE719891C (de) * | 1938-12-08 | 1942-04-21 | Dr Erich Strack | Verfahren zur Herstellung des Methyl- bzw. AEthylesters des acetylierten Carnitins |
US3968241A (en) * | 1972-11-06 | 1976-07-06 | Defelice Stephen L | Method of treating cardiac arrhythmias and of improving myocardial contractility and systolic rhythm with carnitive or a pharmaceutically acceptable salt thereof |
JPS531812B2 (fr) * | 1972-12-07 | 1978-01-23 | ||
JPS5058213A (fr) * | 1973-09-26 | 1975-05-21 | ||
AU518617B2 (en) * | 1977-04-29 | 1981-10-08 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Therapeutic application of acetyl-d, 1-carnitine |
IT1143611B (it) * | 1977-11-03 | 1986-10-22 | Sigma Tau Ind Farmaceuti | Applicazione della acetil-carnitina nella terapia delle affezioni cardiache di/tipo anossico,ischemico,cardiotossico e nelle sindromi aritmiche |
DE2903579A1 (de) * | 1978-02-03 | 1979-08-09 | Sigma Tau Ind Farmaceuti | Verwendung von acetylcarnitin und anderen acylderivaten des carnitins zur behandlung der hyperlipoproteinaemie und hyperlimpidaemie sowie arzneimittel |
-
1979
- 1979-04-23 IT IT48816/79A patent/IT1116037B/it active
-
1980
- 1980-04-21 IE IE801/80A patent/IE49701B1/en not_active IP Right Cessation
- 1980-04-21 GR GR61731A patent/GR68051B/el unknown
- 1980-04-21 GR GR61732A patent/GR68052B/el unknown
- 1980-04-21 IE IE800/80A patent/IE49700B1/en not_active IP Right Cessation
- 1980-04-22 LU LU82387A patent/LU82387A1/fr unknown
- 1980-04-22 DK DK170680A patent/DK170680A/da not_active IP Right Cessation
- 1980-04-22 LU LU82386A patent/LU82386A1/fr unknown
- 1980-04-22 CH CH311180A patent/CH642619A5/it not_active IP Right Cessation
- 1980-04-22 CH CH311080A patent/CH642849A5/it not_active IP Right Cessation
- 1980-04-22 DK DK170580A patent/DK155595C/da not_active IP Right Cessation
- 1980-04-22 NO NO801155A patent/NO151823C/no unknown
- 1980-04-22 NO NO801154A patent/NO151822C/no unknown
- 1980-04-22 ES ES490764A patent/ES8104191A1/es not_active Expired
- 1980-04-22 SE SE8003004A patent/SE448375B/sv not_active IP Right Cessation
- 1980-04-22 ES ES490765A patent/ES8104987A1/es not_active Expired
- 1980-04-22 SE SE8003005A patent/SE447244B/sv not_active IP Right Cessation
- 1980-04-22 AT AT0215780A patent/AT376656B/de not_active IP Right Cessation
- 1980-04-22 AT AT0215680A patent/AT375336B/de not_active IP Right Cessation
- 1980-04-23 NL NL8002369A patent/NL8002369A/nl not_active Application Discontinuation
- 1980-04-23 AU AU57738/80A patent/AU538740B2/en not_active Expired
- 1980-04-23 DE DE19803015635 patent/DE3015635A1/de active Granted
- 1980-04-23 GB GB8013428A patent/GB2051779B/en not_active Expired
- 1980-04-23 JP JP5482280A patent/JPS562945A/ja active Granted
- 1980-04-23 AU AU57736/80A patent/AU538739B2/en not_active Expired
- 1980-04-23 JP JP5482180A patent/JPS55167262A/ja active Granted
- 1980-04-23 BE BE0/200345A patent/BE882937A/fr not_active IP Right Cessation
- 1980-04-23 FR FR8009148A patent/FR2455027B1/fr not_active Expired
- 1980-04-23 DE DE3015636A patent/DE3015636C2/de not_active Expired - Lifetime
- 1980-04-23 FR FR8009149A patent/FR2455028A1/fr active Granted
- 1980-04-23 BE BE0/200344A patent/BE882936A/fr not_active IP Right Cessation
- 1980-04-23 GB GB8013429A patent/GB2048268B/en not_active Expired
- 1980-04-23 NL NL8002370A patent/NL8002370A/nl not_active Application Discontinuation
- 1980-04-24 IL IL59915A patent/IL59915A/xx unknown
- 1980-04-24 IL IL59914A patent/IL59914A/xx unknown
-
1982
- 1982-05-26 US US06/382,275 patent/US4443475A/en not_active Expired - Lifetime
- 1982-05-26 US US06/382,319 patent/US4439438A/en not_active Expired - Lifetime
-
1990
- 1990-10-03 JP JP2267503A patent/JPH03236318A/ja active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4032641A (en) * | 1976-06-09 | 1977-06-28 | Tanabe Seiyaku Co., Ltd. | Nicotinoyl carnitine derivatives |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2474489A1 (fr) * | 1980-01-29 | 1981-07-31 | Sigma Tau Ind Farmaceuti | Carnitinamides d'aminoacides optiquement actifs, leur procede de preparation et leur application en therapeutique |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2455028A1 (fr) | Nouveaux amides d'acylcarnitines, utiles notamment comme stimulants du systeme nerveux central, et leur procede de preparation | |
FR2448347A1 (fr) | Composition pharmaceutique comprenant une acyl-carnitine pour le traitement des maladies vasculaires peripheriques | |
FR2430410A1 (fr) | Phenethanolamines et compositions pharmaceutiques en contenant | |
ES2039203T3 (es) | Composicion de liposomas. | |
FR2381521A1 (fr) | Base pour des preparations medicamenteuses a usage externe, preparation medicamenteuses preparees a l'aide de celle-ci et procede pour leur preparation | |
FR2541115B1 (fr) | Medicament renfermant un peptide en tant que principe actif pour le traitement des affections ulcereuses | |
FR2385682A1 (fr) | Nouveaux 1-amino-indanes et leur utilisation comme medicaments | |
SE8002322L (sv) | Medel for behandling av inflammatoriska tarmsjukdomar | |
FR2393577A1 (fr) | Medicament a base d'acide b-(p-halogenophenyl)-g-aminobutyrique destine au traitement de la nevrose d'angoisse | |
FR2358382A1 (fr) | Nouveaux nonapeptides, leurs procedes de preparation et compositions pharmaceutiques les contenant | |
FR2445329A1 (fr) | Derives du 11-bromo-14-oxo-15-hydroxy-imino-e-homo-eburnane, leur preparation et leur utilisation comme medicament | |
FR2405067A1 (fr) | Compositions pharmaceutiques contenant des derives monofonctionnels du psoralene pour le traitement des affections cutanees | |
FR2448899A1 (fr) | Utilisation therapeutique de l'acide 6,7-dichloro-3,4-dihydro-3-oxo-2-quinoxalinecarboxylique et de ses esters | |
FR2400012A1 (fr) | Derives alpha-acetyleniques d'alpha-aminoacides, leur preparation et leur utilisation comme agent anti-infectieux | |
FR2420344A1 (fr) | Nouveaux oxime-ethers, leur preparation et leur application therapeutique. | |
US3935313A (en) | Pharmaceutical composition containing N-(3-diethyl-aminopropyl)-4-nitro-1-oxide-pyridine-2-carboxamide and process for the treatment of hypertension therewith | |
FR2361361A1 (fr) | Nouveaux derives du cyclopentane et medicaments contenant ces substances | |
FR2421613A1 (fr) | Compositions contenant des benzamides de 3-aminopyrrolidines et leur utilisation therapeutique pour le traitement des allergies | |
FR2442239A1 (fr) | Procede de preparation de 4,l-benzoxazepines et de leur analogue thia, nouveaux produits ainsi obtenus et leur utilisation pour le traitement de troubles mentaux | |
EP0176929A3 (fr) | Compositions pharmaceutiques comprenant des diazépines à l'action antagoniste du facteur d'activation de plaquettes (PAF) | |
FR2380778A1 (fr) | Compositions pharmaceutiques contenant des acides oxaniliques substitues ou leurs esters | |
FR2376145A1 (fr) | Nouveaux derives de chromones a activite medicamenteuse et leur preparation | |
FR2370727A1 (fr) | Nouveaux derives substitues de o-phenylenediamine, leur procede de preparation et medicament les contenant | |
HUP9903892A2 (hu) | Hidroxámsavszármazékok | |
FR2455569A1 (fr) | Nouvelles isoprenylamines et leurs sels acides d'addition et leur utilisation comme substances actives dans des compositions pharmaceutiques antivirales pour animaux vertebres |